A phase Ib/II study of cabozantinib (XL184) with or without erlotinib in patients with non-small cell lung cancer

Heather A. Wakelee, Scott Gettinger, Jeffrey Engelman, Pasi A. Jänne, Howard West, Deepa S. Subramaniam, Joseph Leach, Michael Wax, Yifah Yaron, Dale R. Miles, Primo N. Lara

Research output: Contribution to journalArticlepeer-review

29 Scopus citations

Fingerprint

Dive into the research topics of 'A phase Ib/II study of cabozantinib (XL184) with or without erlotinib in patients with non-small cell lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds